FDA finalizes guidance on developing, manufacturing CAR T therapies

Regulatory NewsRegulatory NewsAdvanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesNorth AmericaRegulatory Intelligence/PolicyUnited States